Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients
Open Access
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (9) , 1802-1807
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL91744, HL036444, CA18029, CA 78902, AI33484, HL087690)
This publication has 37 references indexed in Scilit:
- Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene PolymorphismTransplantation Proceedings, 2017
- Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohortTransplant International, 2011
- Proton Pump Inhibitors Reduce Mycophenolate Exposure in Heart Transplant Recipients-A Prospective Case-Controlled StudyAmerican Journal of Transplantation, 2009
- Polymorphisms of cytokine and innate immunity genes and GVHDBest Practice & Research Clinical Haematology, 2008
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant RecipientsClinical Pharmacokinetics, 2007
- IMPDH1 promoter mutations in a patient exhibiting azathioprine resistanceThe Pharmacogenomics Journal, 2006
- Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil DosingJournal of the American Society of Nephrology, 2006
- Pharmacogenetics in Immunosuppressive TherapyTherapeutic Drug Monitoring, 2004
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsBlood, 2001
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974